Oberweis Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Oberweis Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-140,180	Closed	-$8.78M	–	226
2019 Q1	$8.78M	Sell	140,180 -34,770	-20%	-$2.39M	1.76%	9
2018 Q4	$10.4M	Buy	174,950 +13,620	+8%	+$818K	2.34%	6
2018 Q3	$10.4M	Buy	+161,330	New	+$9M	2.02%	4
2017 Q4	–	Sell	-14,400	Closed	-$475K	–	251
2017 Q3	$475K	Sell	14,400 -11,300	-44%	-$391K	0.13%	115
2017 Q2	$860K	Sell	25,700 -17,300	-40%	-$516K	0.24%	88
2017 Q1	$1.25M	Sell	43,000 -6,700	-13%	-$166K	0.37%	58
2016 Q4	$1.11M	Buy	49,700 +5,500	+12%	+$108K	0.33%	56
2016 Q3	$821K	Buy	44,200 +1,600	+4%	+$30.2K	0.24%	71
2016 Q2	$694K	Buy	+42,600	New	+$627K	0.21%	72

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Oberweis Asset Management's BEAT Position: Q2 2019 in Review

Oberweis Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 140,180 shares — an estimated $8.78M sold.

Oberweis Asset Management first reported a position in BEAT in Q2 2016 and held it in 9 quarters. The position peaked at $10.4M in Q4 2018. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

Oberweis Asset Management reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
Oberweis Asset Management sold 140,180 BioTelemetry, Inc. shares in Q2 2019, an estimated $8.78M.
Oberweis Asset Management first reported a position in BioTelemetry, Inc. in Q2 2016 and held it in 9 quarters.
Oberweis Asset Management's BioTelemetry, Inc. position peaked at $10.4M in Q4 2018.
251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Oberweis Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.